Aceto, manufacturer of specialty materials for life sciences and advanced technology, announced the acquisition of New York based, IsleChem. IsleChem’s technical, analytical and manufacturing expertise complements Aceto and expands its value-added offering to customers.

The acquisition represents an important step in Aceto’s long-term growth strategy. By adding manufacturing expertise in the U.S., Aceto builds upon its robust global supply network focused in India and China to offer access to an increasingly diversified set of products and capabilities worldwide.

“The COVID pandemic has reinforced that access to a diverse, secure supply chain and dependable manufacturing is essential to business continuity,” said Gilles Cottier, Chief Executive Officer of Aceto. “This acquisition adds manufacturing and R&D capabilities to enhance Aceto’s already robust supply network.  IsleChem is poised for facility expansion to service growing market demand, allowing the combined company to support more of our customers’ needs from development through to commercialization and full-scale production.”

“IsleChem and Aceto share the same core value of highest quality service and both companies are intently focused on meeting the needs of our customers,” said Pat Canavan, President of IsleChem. “Joining forces gives us access to Aceto’s experienced salesforce in the U.S. and Europe, which helps us to service additional markets and enhance our value to customers.”

IsleChem’s core business includes chemical manufacturing, contract research and development (R&D), analytical services, and technical and support services, which complement Aceto’s proven leadership in chemical sourcing, quality, and supply chain. The combination of Aceto and IsleChem enhances Aceto’s established reputation for providing specialty solutions to customers around the world.